Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

How We Interpret Thrombosis with Thrombocytopenia Syndrome?

Yamada, Shinya; Asakura, Hidesaku.

Int J Mol Sci ; 25(9)2024 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-38732176

2.

Consideration of Tranexamic Acid Administration to COVID-19 Patients.

Ogawa, Haruhiko; Asakura, Hidesaku.

Physiol Rev ; 100(4): 1595-1596, 2020 10 01.

Artículo en Inglés | MEDLINE | ID: mdl-32639181

3.

Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.

Yamada, Shinya; Asakura, Hidesaku.

Int J Mol Sci ; 23(3)2022 Jan 24.

Artículo en Inglés | MEDLINE | ID: mdl-35163216

4.

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.

Yamada, Shinya; Asakura, Hidesaku.

Int J Mol Sci ; 23(6)2022 Mar 19.

Artículo en Inglés | MEDLINE | ID: mdl-35328761

5.

[Improving outcome of COVID-19-associated thrombosis: the need for evaluation of fibrinolytic activation].

Yamada, Shinya; Asakura, Hidesaku.

Rinsho Ketsueki ; 63(5): 471-480, 2022.

Artículo en Japonés | MEDLINE | ID: mdl-35662173

6.

[Acquired factor V inhibitor].

Yamada, Shinya; Asakura, Hidesaku.

Rinsho Ketsueki ; 61(7): 791-798, 2020.

Artículo en Japonés | MEDLINE | ID: mdl-32759567

7.

Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.

Ito, Takashi; Thachil, Jecko; Asakura, Hidesaku; Levy, Jerrold H; Iba, Toshiaki.

Crit Care ; 23(1): 280, 2019 08 15.

Artículo en Inglés | MEDLINE | ID: mdl-31416465

8.

[DIC: state-of-the-art in diagnosis and management].

Asakura, Hidesaku.

Rinsho Ketsueki ; 60(6): 659-666, 2019.

Artículo en Japonés | MEDLINE | ID: mdl-31281159

9.

Congenital coagulation factor X deficiency: Genetic analysis of five patients and functional characterization of mutant factor X proteins.

Nagaya, Satomi; Akiyama, Masashi; Murakami, Morika; Sekiya, Akiko; Asakura, Hidesaku; Morishita, Eriko.

Haemophilia ; 24(5): 774-785, 2018 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-30152566

10.

[Thrombosis in myeloproliferative neoplasms].

Asakura, Hidesaku.

Rinsho Ketsueki ; 59(8): 1034-1041, 2018.

Artículo en Japonés | MEDLINE | ID: mdl-30185703

11.

The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

Wada, Hideo; Takahashi, Hoyu; Uchiyama, Toshimasa; Eguchi, Yutaka; Okamoto, Kohji; Kawasugi, Kazuo; Madoiwa, Seiji; Asakura, Hidesaku.

Thromb J ; 15: 17, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28680365

12.

[Overview].

Asakura, Hidesaku.

Rinsho Ketsueki ; 63(5): 440, 2022.

Artículo en Japonés | MEDLINE | ID: mdl-35662169

13.

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

Asakura, Hidesaku; Takahashi, Hoyu; Uchiyama, Toshimasa; Eguchi, Yutaka; Okamoto, Kohji; Kawasugi, Kazuo; Madoiwa, Seiji; Wada, Hideo.

Thromb J ; 14: 42, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-27708553

14.

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.

Iba, Toshiaki; Di Nisio, Marcello; Thachil, Jecko; Wada, Hideo; Asakura, Hidesaku; Sato, Koichi; Kitamura, Naoya; Saitoh, Daizoh.

Crit Care ; 20: 287, 2016 Sep 14.

Artículo en Inglés | MEDLINE | ID: mdl-27629997

15.

Possibility of PMX-DHP therapy as a principal strategy against cytokine storm in COVID-19: Insights from reconstructed coagulation data.

Ogawa, Haruhiko; Kakuchi, Yasushi; Asakura, Hidesaku.

J Clin Apher ; 36(5): 785-786, 2021 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-34252978

16.

[Classifying types of DIC: clinical features and animal models].

Asakura, Hidesaku.

Rinsho Ketsueki ; 57(4): 397-404, 2016 Apr.

Artículo en Japonés | MEDLINE | ID: mdl-27169441

17.

Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.

Tamura, Kazuo; Saito, Hidehiko; Asakura, Hidesaku; Okamoto, Kohji; Tagawa, Jun; Hayakawa, Toru; Aoki, Nobuo.

Int J Clin Oncol ; 20(4): 821-8, 2015 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-25385713

18.

Adjunctive therapies for early withdrawal from extracorporeal membrane oxygenation.

Ogawa, Haruhiko; Kakuchi, Yasushi; Asakura, Hidesaku.

J Card Surg ; 35(12): 3671-3672, 2020 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-32989829

19.

The first reported case of acquired haemophilia A in which bleeding episodes were successfully treated via administration of a single-dose mixture of activated factor VIIa/X.

Yamada, Shinya; Arahata, Masahisa; Morishita, Eriko; Ichinose, Akitada; Asakura, Hidesaku.

Haemophilia ; 25(5): e350-e352, 2019 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-31487088

20.

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.

Iba, Toshiaki; Saitoh, Daizoh; Wada, Hideo; Asakura, Hidesaku.

Crit Care ; 18(5): 497, 2014 Sep 15.

Artículo en Inglés | MEDLINE | ID: mdl-25220851

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

How We Interpret Thrombosis with Thrombocytopenia Syndrome?

Consideration of Tranexamic Acid Administration to COVID-19 Patients.

Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.

[Improving outcome of COVID-19-associated thrombosis: the need for evaluation of fibrinolytic activation].

[Acquired factor V inhibitor].

Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.

[DIC: state-of-the-art in diagnosis and management].

Congenital coagulation factor X deficiency: Genetic analysis of five patients and functional characterization of mutant factor X proteins.

[Thrombosis in myeloproliferative neoplasms].

The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

[Overview].

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.

Possibility of PMX-DHP therapy as a principal strategy against cytokine storm in COVID-19: Insights from reconstructed coagulation data.

[Classifying types of DIC: clinical features and animal models].

Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.

Adjunctive therapies for early withdrawal from extracorporeal membrane oxygenation.

The first reported case of acquired haemophilia A in which bleeding episodes were successfully treated via administration of a single-dose mixture of activated factor VIIa/X.

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.